{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T22:16:45Z","timestamp":1768601805641,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[1993,4,1]],"date-time":"1993-04-01T00:00:00Z","timestamp":733622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[1993,4]]},"DOI":"10.1016\/0014-2999(93)90952-e","type":"journal-article","created":{"date-parts":[[2002,12,14]],"date-time":"2002-12-14T00:19:26Z","timestamp":1039825166000},"page":"183-189","source":"Crossref","is-referenced-by-count":6,"title":["Hypotensive action of 5-HT receptor agonists in the vitamin B6-deficient hypertensive rat"],"prefix":"10.1016","volume":"234","author":[{"given":"Kovvuri","family":"Jawahar Lal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishnamurti","family":"Dakshinamurti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0014-2999(93)90952-E_BIB1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/01.HYP.4.6.898","article-title":"Tail cuff blood pressure measurement without external preheating in awake rats","volume":"4","author":"Bunang","year":"1982","journal-title":"Hypertension"},{"key":"10.1016\/0014-2999(93)90952-E_BIB2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1471-4159.1969.tb09906.x","article-title":"Pyridoxine deficiency in the neonate rat","volume":"16","author":"Dakshinamurti","year":"1969","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/0014-2999(93)90952-E_BIB3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000421666","article-title":"Vitamins and hypertension","volume":"69","author":"Dakshinamurti","year":"1992","journal-title":"World. Rev. Nutr. Diet."},{"key":"10.1016\/0014-2999(93)90952-E_BIB4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1749-6632.1990.tb28049.x","article-title":"Neurobiology of pyridoxine","volume":"585","author":"Dakshinamurti","year":"1990","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/0014-2999(93)90952-E_BIB5","series-title":"New Perspectives in Serotonin Pharmacology","first-page":"1","article-title":"Antihypertensive effects of 5-HT1A receptor activation in an animal model of hypertension","author":"Dakshinamurti","year":"1991"},{"key":"10.1016\/0014-2999(93)90952-E_BIB6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1474-8673.1986.tb00632.x","article-title":"The cardiovascular effects of centrally administered 5-hydroxytryptamine in the conscious normotensive and hypertensive rat","volume":"6","author":"Dalton","year":"1986","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/0014-2999(93)90952-E_BIB7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0014-2999(90)90319-2","article-title":"Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat","volume":"180","author":"Dreteler","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/0014-2999(93)90952-E_BIB8","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00005344-198703000-00010","article-title":"Cardiovascular response to 8-hydroxy-2 (di-n-propylamino) tetralin in the rat: Site of action and pharmacological analysis","volume":"9","author":"Fozard","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/0014-2999(93)90952-E_BIB9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/BF00165749","article-title":"Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for \u03b11-adrenoceptor binding sites","volume":"336","author":"Gro\u03b2","year":"1987","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/0014-2999(93)90952-E_BIB10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF00965212","article-title":"Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents","volume":"11","author":"Hall","year":"1986","journal-title":"Neurochem. Res."},{"key":"10.1016\/0014-2999(93)90952-E_BIB11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-2999(83)90382-5","article-title":"Hypotensive activity of serotonin receptor agonists in rats is related to their affinity for 5-HT1 receptors","volume":"91","author":"Kalkman","year":"1983","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 3","key":"10.1016\/0014-2999(93)90952-E_BIB12","first-page":"143","article-title":"Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats","volume":"2","author":"Kalkman","year":"1984","journal-title":"J. Hypertension"},{"key":"10.1016\/0014-2999(93)90952-E_BIB13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/01.HYP.2.3.243","article-title":"Review of the role of the central serotonergic neuronal system in blood pressure regulation","volume":"2","author":"Kuhn","year":"1980","journal-title":"Hypert."},{"key":"10.1016\/0014-2999(93)90952-E_BIB14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00505480","article-title":"Comparison of the pharmacological characteristics of 5-HT1 and 5-HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release","volume":"321","author":"Martin","year":"1982","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/0014-2999(93)90952-E_BIB15","series-title":"5-HT Agonists as Psychoactive Drugs","first-page":"143","article-title":"Role of serotonin receptor subtypes in the central regulation of blood pressure","author":"McCall","year":"1988"},{"key":"10.1016\/0014-2999(93)90952-E_BIB16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00053423","article-title":"Central serotonergic mechanisms in cardiovascular regulation","volume":"4","author":"Minson","year":"1990","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/0014-2999(93)90952-E_BIB17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-2999(86)90147-0","article-title":"Spiroxatrine: a selective serotonin1A receptor antagonist","volume":"124","author":"Nelson","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/0014-2999(93)90952-E_BIB18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1152\/physrev.1954.34.3.563","article-title":"Serotonin (5-hydroxytryptamine)","volume":"34","author":"Page","year":"1954","journal-title":"Physiol. Rev."},{"key":"10.1016\/0014-2999(93)90952-E_BIB19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/01.HYP.11.4.387","article-title":"Sympathetic stimulation and hypertension in the pyridoxine-deficient adult rat","volume":"11","author":"Paulose","year":"1988","journal-title":"Hypertension"},{"key":"10.1016\/0014-2999(93)90952-E_BIB20","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1471-4159.1981.tb02397.x","article-title":"Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain","volume":"36","author":"Pedigo","year":"1981","journal-title":"J. Neurochem."},{"key":"10.1016\/0014-2999(93)90952-E_BIB21","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0006-8993(85)91202-8","article-title":"Regulation of central \u03b1-adrenoreceptor by serotonergic denervation","volume":"344","author":"Rapaport","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/0014-2999(93)90952-E_BIB22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(85)90210-9","article-title":"Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats","volume":"110","author":"Sanders","year":"1985","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 4","key":"10.1016\/0014-2999(93)90952-E_BIB23","first-page":"49","article-title":"Urapidil and some analogs with high affinities for serotonin 1A and \u03b11-adrenoceptor binding sites show potent hypotensive activity upon central administration","volume":"4","author":"Sanders","year":"1989","journal-title":"Curr. Opinion Cardiol."},{"key":"10.1016\/0014-2999(93)90952-E_BIB24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1472-8206.1989.tb00455.x","article-title":"Cardiovascular effects from stimulation of 5-hydroxytryptamine receptors","volume":"3","author":"Saxena","year":"1989","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"Suppl. 3","key":"10.1016\/0014-2999(93)90952-E_BIB25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005344-198706103-00005","article-title":"Serotonin agonists and antagonists in experimental hypertension","volume":"10","author":"Saxena","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"Suppl. II","key":"10.1016\/0014-2999(93)90952-E_BIB26","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1111\/j.1600-0773.1992.tb01617.x","article-title":"Serotonergic receptors and drugs in hypertension","volume":"70","author":"Van Zwieten","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/0014-2999(93)90952-E_BIB27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-3940(90)90368-J","article-title":"Alterations in brain stem \u03b12-adrenoreceptor activity in pyridoxine-deficient rat model of hypertension","volume":"111","author":"Viswanathan","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/0014-2999(93)90952-E_BIB28","series-title":"Serotonin and the Cardiovascular System","first-page":"63","article-title":"Serotonin and central regulation of arterial blood pressure","author":"Wolf","year":"1985"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:001429999390952E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:001429999390952E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T04:54:19Z","timestamp":1554180859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/001429999390952E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,4]]},"references-count":28,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[1993,4]]}},"alternative-id":["001429999390952E"],"URL":"https:\/\/doi.org\/10.1016\/0014-2999(93)90952-e","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[1993,4]]}}}